Table 1.
Baseline characteristics of prostate cancer cases
Variables | No. patients | % patients | Mean (SD) |
---|---|---|---|
Age (yrs) at diagnosis | 20 | – | 56.60 (8.05) |
Race | |||
African American | 2 | 10 | |
European American | 18 | 90 | |
Gleason score | |||
5–6 | 10 | 50 | |
7(3+4) | 8 | 40 | |
8–10 | 2 | 10 | |
Pathological stage | |||
Local | 13 | 65 | |
Regional | 7 | 35 | |
PSA (ng/mL) at diagnosis | |||
<4 | 1 | 5 | |
4–9.9 | 13 | 65 | |
10–19.9 | 4 | 20 | |
20+ | 1 | 5 |
Abbreviations: PSA, prostate-specific antigen; SD, standard deviation